Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Guggenheim 6th Annual Biotechnology Conference

Feb 7, 2024 10:30 AM EST